Angiogenesis Precedes Breast Cancer Development, Van Nuys Study Shows

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 23 No 5
Volume 23
Issue 5

SAN ANTONIO--Mammographic signs of angiogenesis and neovascularity may identify a developing breast cancer years before the lesion becomes visible, Parvis Gamagami, MD, said at the San Antonio Breast Cancer symposium.

SAN ANTONIO--Mammographic signs of angiogenesis and neovascularitymay identify a developing breast cancer years before the lesionbecomes visible, Parvis Gamagami, MD, said at the San AntonioBreast Cancer symposium.

At The Breast Center, Van Nuys, Calif, a review of xeromammogramsof 204 breast cancer patients, made up to 13 years before cancerdetection, showed that vascular evidence of tumor developmentpreceded the mammographic appearance of 91% of nonpalpable lesionsand 100% of advanced palpable lesions.

Signs of tumor-related angiogenesis include hypervascularity,vessel dilation or engorgement, focally convergent vessels, andespecially calcification of the nutrient artery of the carcinoma(for unknown reason). "If a single calcified vessel appearsin only one breast without evidence of malignancy, that is a strongindication of high risk," said Dr. Gamagami, a radiologistat the Van Nuys Breast Center.

He believe that mammographic evidence of angiogenesis can be usedto identify very small, early-stage lesions that otherwise couldbe missed. In their study, they identified vessel convergencein malignancies as small as 5 mm.

Evidence of tumor angiogenesis is often dismissed as benign vascularityor nonpathologic asymmetry, Dr. Gama-gami said. In some instances,the signs are simply overlooked.

Patients with evidence of breast cancer angiogenesis should befollowed closely, probably with annual mammograms, at least inthe affected breast, Dr. Gamagami advised. "We know thata preneoplastic condition exists years before malignant transformationoccurs," he said. "We don't have any criteria to helpus decide which breast or breasts will develop cancer. Angiogenesismay be helpful in that respect, so when we see a single calcifiedartery, we have to follow its itinerary to see where it ends."

Investigators at Van Nuys have begun evaluating the use of corebiopsy in women who have suspicious vessels that end in areasof parenchymal hyperdensity, one characteristic of malignancy.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.
Related Content